{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:40:09Z","timestamp":1793907609413,"version":"4.8.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T00:00:00Z","timestamp":1657497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T00:00:00Z","timestamp":1657497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["17122519"],"award-info":[{"award-number":["17122519"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["17126317"],"award-info":[{"award-number":["17126317"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32000616"],"award-info":[{"award-number":["32000616"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"DOI":"10.1038\/s41423-022-00894-x","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T06:04:45Z","timestamp":1657605885000},"page":"944-956","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Glucose metabolism controls human \u03b3\u03b4 T-cell-mediated tumor immunosurveillance in diabetes"],"prefix":"10.1038","volume":"19","author":[{"given":"Xiaofeng","family":"Mu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe Ran","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhinan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing-hang","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4780-0289","authenticated-orcid":false,"given":"Yu-Lung","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwei","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,11]]},"reference":[{"key":"894_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","volume":"138","author":"NH Cho","year":"2018","unstructured":"Cho NH, Shawe JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271\u201381. https:\/\/doi.org\/10.1016\/j.diabres.2018.02.023.","journal-title":"Diabetes Res Clin Pract"},{"key":"894_CR2","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/dme.12791","volume":"32","author":"N Holman","year":"2015","unstructured":"Holman N, Young B, Gadsby R. Current prevalence of Type 1 and Type 2 diabetes in adults and children in the UK. Diabet Med. 2015;32:1119\u201320. https:\/\/doi.org\/10.1111\/dme.12791.","journal-title":"Diabet Med"},{"key":"894_CR3","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.2337\/diacare.28.11.2613","volume":"28","author":"G Bruno","year":"2005","unstructured":"Bruno G, Runzo C, Cavallo-Perin P, Merlletti F, Rivetti M, Pinach S, et al. Incidence of type 1 and type 2 diabetes in adults aged 30-49 years: the population-based registry in the province of Turin, Italy. Diabetes Care. 2005;28:2613\u20139. https:\/\/doi.org\/10.2337\/diacare.28.11.2613.","journal-title":"Diabetes Care"},{"key":"894_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.5001\/omj.2012.68","volume":"27","author":"AB Olokoba","year":"2012","unstructured":"Olokoba AB, Obateru OA, Olokoba LB. Type 2 diabetes mellitus: a review of current trends. Oman Med J. 2012;27:269\u201373. https:\/\/doi.org\/10.5001\/omj.2012.68.","journal-title":"Oman Med J"},{"key":"894_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3322\/caac.20078","volume":"60","author":"E Giovannucci","year":"2010","unstructured":"Giovannucci E, Harlan DM, Archer MC, Bergenstalet RM, Gapstur SM, Habel LA, et al. Diabetes and cancer: a consensus report. CA Cancer J Clin. 2010;60:207\u201321. https:\/\/doi.org\/10.3322\/caac.20078.","journal-title":"CA Cancer J Clin"},{"key":"894_CR6","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1200\/JCO.2016.67.4044","volume":"34","author":"G Shlomai","year":"2016","unstructured":"Shlomai G, Neel B, LeRoith D, Gallagher EJ. Type 2 diabetes mellitus and cancer: the role of pharmacotherapy. J Clin Oncol. 2016;34:4261\u20139. https:\/\/doi.org\/10.1200\/JCO.2016.67.4044.","journal-title":"J Clin Oncol"},{"key":"894_CR7","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.biopha.2018.07.157","volume":"107","author":"B Giri","year":"2018","unstructured":"Giri B, Dey S, Das T, Sarkar M, Banerjee J, Dash SK, et al. Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: an update on glucose toxicity. Biomed Pharmacother. 2018;107:306\u201328. https:\/\/doi.org\/10.1016\/j.biopha.2018.07.157.","journal-title":"Biomed Pharmacother"},{"key":"894_CR8","doi-asserted-by":"publisher","first-page":"7457269","DOI":"10.1155\/2018\/7457269","volume":"2018","author":"T Zhou","year":"2018","unstructured":"Zhou T, Hu Z, Yang S, Sun L, Yu Z, Wang G, et al. Role of adaptive and innate immunity in type 2 diabetes mellitus. J Diabetes Res. 2018;2018:7457269. https:\/\/doi.org\/10.1155\/2018\/7457269.","journal-title":"J Diabetes Res"},{"key":"894_CR9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2174\/1389450033490966","volume":"4","author":"FB Stentz","year":"2003","unstructured":"Stentz FB, Kitabchi AE. Activated T lymphocytes in Type 2 diabetes: implications from in vitro studies. Curr Drug Targets. 2003;4:493\u2013503. https:\/\/doi.org\/10.2174\/1389450033490966.","journal-title":"Curr Drug Targets"},{"key":"894_CR10","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00281-019-00736-5","volume":"41","author":"E Dalmas","year":"2019","unstructured":"Dalmas E. Role of innate immune cells in metabolism: from physiology to type 2 diabetes. Semin Immunopathol. 2019;41:531\u201345. https:\/\/doi.org\/10.1007\/s00281-019-00736-5.","journal-title":"Semin Immunopathol"},{"key":"894_CR11","doi-asserted-by":"publisher","first-page":"6494795","DOI":"10.1155\/2017\/6494795","volume":"2017","author":"C Xia","year":"2017","unstructured":"Xia C, Rao X, Zhong J. Role of T lymphocytes in type 2 diabetes and diabetes-associated inflammation. J Diabetes Res. 2017;2017:6494795. https:\/\/doi.org\/10.1155\/2017\/6494795.","journal-title":"J Diabetes Res"},{"key":"894_CR12","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1002\/JLB.MR0718-260R","volume":"105","author":"CM Gardiner","year":"2019","unstructured":"Gardiner CM. NK cell metabolism. J Leukoc Biol. 2019;105:1235\u201342. https:\/\/doi.org\/10.1002\/JLB.MR0718-260R.","journal-title":"J Leukoc Biol"},{"key":"894_CR13","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.it.2017.03.001","volume":"38","author":"J Van den Bossche","year":"2017","unstructured":"Van den Bossche J, O\u2019Neill LA, Menon D. Macrophage immunometabolism: where are we (going)? Trends Immunol. 2017;38:395\u2013406. https:\/\/doi.org\/10.1016\/j.it.2017.03.001.","journal-title":"Trends Immunol"},{"key":"894_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/cei.13187","volume":"194","author":"HW Nam","year":"2018","unstructured":"Nam HW, Cho YJ, Lim JA, Kim SJ, Kim H, Sim SY, et al. Functional status of immune cells in patients with long-lasting type 2 diabetes mellitus. Clin Exp Immunol. 2018;194:125\u201336. https:\/\/doi.org\/10.1111\/cei.13187.","journal-title":"Clin Exp Immunol"},{"key":"894_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41423-020-00561-z","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen Y, Tian Z. Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer. Cell Mol Immunol. 2021;18:57\u201372. https:\/\/doi.org\/10.1038\/s41423-020-00561-z.","journal-title":"Cell Mol Immunol"},{"key":"894_CR16","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41423-020-0504-x","volume":"17","author":"D Kabelitz","year":"2020","unstructured":"Kabelitz D, Serrano R, Kouakanou L, Peters C, Kalyan S. Cancer immunotherapy with gammadelta T cells: many paths ahead of us. Cell Mol Immunol. 2020;17:925\u201339. https:\/\/doi.org\/10.1038\/s41423-020-0504-x.","journal-title":"Cell Mol Immunol"},{"key":"894_CR17","doi-asserted-by":"publisher","first-page":"eabb0192","DOI":"10.1126\/scitranslmed.abb0192","volume":"13","author":"E Foord","year":"2021","unstructured":"Foord E, Arruda LCM, Gaballa A, Klynning C, Uhlin M. Characterization of ascites- and tumor-infiltrating gammadelta T cells reveals distinct repertoires and a beneficial role in ovarian cancer. Sci Transl Med. 2021;13:eabb0192. https:\/\/doi.org\/10.1126\/scitranslmed.abb0192.","journal-title":"Sci Transl Med"},{"key":"894_CR18","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3389\/fimmu.2017.01041","volume":"8","author":"Z Xiang","year":"2017","unstructured":"Xiang Z, Tu W. Dual face of Vgamma9Vdelta2-T cells in tumor immunology: anti- versus pro-tumoral activities. Front Immunol. 2017;8:1041. https:\/\/doi.org\/10.3389\/fimmu.2017.01041.","journal-title":"Front Immunol"},{"key":"894_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.4049\/jimmunol.1800934","volume":"203","author":"AC Hayday","year":"2019","unstructured":"Hayday AC. gammadelta T cell update: adaptate orchestrators of immune surveillance. J Immunol. 2019;203:311\u201320. https:\/\/doi.org\/10.4049\/jimmunol.1800934.","journal-title":"J Immunol"},{"key":"894_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.smim.2010.03.006","volume":"22","author":"RL O\u2019Brien","year":"2010","unstructured":"O\u2019Brien RL, Born WK. gammadelta T cell subsets: a link between TCR and function? Semin Immunol. 2010;22:193\u20138. https:\/\/doi.org\/10.1016\/j.smim.2010.03.006.","journal-title":"Semin Immunol"},{"key":"894_CR21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nri3384","volume":"13","author":"P Vantourout","year":"2013","unstructured":"Vantourout P, Hayday A. Six-of-the-best: unique contributions of gammadelta T cells to immunology. Nat Rev Immunol. 2013;13:88\u2013100. https:\/\/doi.org\/10.1038\/nri3384.","journal-title":"Nat Rev Immunol"},{"key":"894_CR22","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nri2781","volume":"10","author":"M Bonneville","year":"2010","unstructured":"Bonneville M, O\u2019Brien RL, Born WK. Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat Rev Immunol. 2010;10:467\u201378. https:\/\/doi.org\/10.1038\/nri2781.","journal-title":"Nat Rev Immunol"},{"key":"894_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.coi.2005.11.007","volume":"18","author":"WK Born","year":"2006","unstructured":"Born WK, Reardon CL, O\u2019Brien RL. The function of gammadelta T cells in innate immunity. Curr Opin Immunol. 2006;18:31\u201338. https:\/\/doi.org\/10.1016\/j.coi.2005.11.007.","journal-title":"Curr Opin Immunol"},{"key":"894_CR24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/cmi.2012.43","volume":"10","author":"J Zheng","year":"2013","unstructured":"Zheng J, Liu Y, Lau YL, Tu W. gammadelta-T cells: an unpolished sword in human anti-infection immunity. Cell Mol Immunol. 2013;10:50\u201357. https:\/\/doi.org\/10.1038\/cmi.2012.43.","journal-title":"Cell Mol Immunol"},{"key":"894_CR25","doi-asserted-by":"publisher","first-page":"e0135999","DOI":"10.1371\/journal.pone.0135999","volume":"10","author":"J Zheng","year":"2015","unstructured":"Zheng J, Wu WL, Liu Y, Xiang Z, Liu M, Chan KH, et al. The therapeutic effect of pamidronate on lethal avian influenza A H7N9 virus infected humanized mice. PLoS One. 2015;10:e0135999. https:\/\/doi.org\/10.1371\/journal.pone.0135999.","journal-title":"PLoS One"},{"key":"894_CR26","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/cmi.2012.78","volume":"10","author":"J Li","year":"2013","unstructured":"Li J, Li H, Mao H, Yu M, Feng T, Yang F, et al. Vgamma9Vdelta2-T lymphocytes have impaired antiviral function in small-for-gestational-age and preterm neonates. Cell Mol Immunol. 2013;10:253\u201360. https:\/\/doi.org\/10.1038\/cmi.2012.78.","journal-title":"Cell Mol Immunol"},{"key":"894_CR27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-0174-2","volume":"5","author":"Y Pei","year":"2020","unstructured":"Pei Y, Xiang Z, Huang C, Wang X, Mu X, Wen L, et al. CD137 costimulation enhances the antiviral activity of Vgamma9Vdelta2-T cells against influenza virus. Signal Transduct Target Ther. 2020;5:74. https:\/\/doi.org\/10.1038\/s41392-020-0174-2.","journal-title":"Signal Transduct Target Ther"},{"key":"894_CR28","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41423-020-0515-7","volume":"18","author":"Y Xu","year":"2021","unstructured":"Xu Y, Xiang Z, Alnaggar M, Kouakanou L, Li J, He Y, et al. Allogeneic Vgamma9Vdelta2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer. Cell Mol Immunol. 2021;18:427\u201339. https:\/\/doi.org\/10.1038\/s41423-020-0515-7.","journal-title":"Cell Mol Immunol"},{"key":"894_CR29","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.imbio.2007.10.006","volume":"213","author":"S Beetz","year":"2008","unstructured":"Beetz S, Wesch D, Marischen L, Welte S, Oberg HH, Kabelitz D, et al. Innate immune functions of human gammadelta T cells. Immunobiology. 2008;213:173\u201382. https:\/\/doi.org\/10.1016\/j.imbio.2007.10.006.","journal-title":"Immunobiology"},{"key":"894_CR30","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/nri.2017.101","volume":"17","author":"MM Nielsen","year":"2017","unstructured":"Nielsen MM, Witherden DA, Havran WL. gammadelta T cells in homeostasis and host defence of epithelial barrier tissues. Nat Rev Immunol. 2017;17:733\u201345. https:\/\/doi.org\/10.1038\/nri.2017.101.","journal-title":"Nat Rev Immunol"},{"key":"894_CR31","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1182\/blood-2009-07-234211","volume":"116","author":"A Maniar","year":"2010","unstructured":"Maniar A, Zhang X, Lin W, Gastman BR, Pauza CD, Strome SE, et al. Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement. Blood. 2010;116:1726\u201333. https:\/\/doi.org\/10.1182\/blood-2009-07-234211.","journal-title":"Blood"},{"key":"894_CR32","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3389\/fimmu.2018.00599","volume":"9","author":"Q Chen","year":"2018","unstructured":"Chen Q, Wen K, Lv A, Liu M, Ni K, Xiang Z, et al. Human Vgamma9Vdelta2-T cells synergize CD4(+) T follicular helper cells to produce influenza virus-specific antibody. Front Immunol. 2018;9:599. https:\/\/doi.org\/10.3389\/fimmu.2018.00599.","journal-title":"Front Immunol"},{"key":"894_CR33","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41568-019-0153-5","volume":"19","author":"B Silva-Santos","year":"2019","unstructured":"Silva-Santos B, Mensurado S, Coffelt SB. gammadelta T cells: pleiotropic immune effectors with therapeutic potential in cancer. Nat Rev Cancer. 2019;19:392\u2013404. https:\/\/doi.org\/10.1038\/s41568-019-0153-5.","journal-title":"Nat Rev Cancer"},{"key":"894_CR34","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ccr.2014.07.026","volume":"26","author":"Z Xiang","year":"2014","unstructured":"Xiang Z, Liu Y, Zheng J, Liu M, Lv A, Gao Y, et al. Targeted activation of human Vgamma9Vdelta2-T cells controls epstein-barr virus-induced B cell lymphoproliferative disease. Cancer Cell. 2014;26:565\u201376. https:\/\/doi.org\/10.1016\/j.ccr.2014.07.026.","journal-title":"Cancer Cell"},{"key":"894_CR35","doi-asserted-by":"publisher","first-page":"eaaz3426","DOI":"10.1126\/scitranslmed.aaz3426","volume":"12","author":"X Wang","year":"2020","unstructured":"Wang X, Xiang Z, Liu Y, Huang C, Pei Y, Wang X, et al. Exosomes derived from Vdelta2-T cells control Epstein-Barr virus-associated tumors and induce T cell antitumor immunity. Sci Transl Med. 2020;12:eaaz3426. https:\/\/doi.org\/10.1126\/scitranslmed.aaz3426.","journal-title":"Sci Transl Med"},{"key":"894_CR36","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1001\/jama.281.21.2005","volume":"281","author":"RC Turner","year":"1999","unstructured":"Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA. 1999;281:2005\u201312. https:\/\/doi.org\/10.1001\/jama.281.21.2005.","journal-title":"JAMA"},{"key":"894_CR37","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41586-018-0350-5","volume":"559","author":"D Wu","year":"2018","unstructured":"Wu D, Hu D, Chen H, Shi G, Fetahu I, Wu F, et al. Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer. Nature. 2018;559:637\u201341. https:\/\/doi.org\/10.1038\/s41586-018-0350-5.","journal-title":"Nature"},{"key":"894_CR38","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1182\/blood-2008-04-152041","volume":"112","author":"W Tu","year":"2008","unstructured":"Tu W, Lau YL, Zheng J, Liu Y, Chan PL, Mao H, et al. Efficient generation of human alloantigen-specific CD4+ regulatory T cells from naive precursors by CD40-activated B cells. Blood. 2008;112:2554\u201362. https:\/\/doi.org\/10.1182\/blood-2008-04-152041.","journal-title":"Blood"},{"key":"894_CR39","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/s41590-018-0251-7","volume":"19","author":"X Michelet","year":"2018","unstructured":"Michelet X, Dyck L, Hogan A, Loftus RM, Duquette D, Wei K, et al. Metabolic reprogramming of natural killer cells in obesity limits antitumor responses. Nat Immunol. 2018;19:1330\u201340. https:\/\/doi.org\/10.1038\/s41590-018-0251-7.","journal-title":"Nat Immunol"},{"key":"894_CR40","doi-asserted-by":"publisher","first-page":"6329","DOI":"10.1073\/pnas.0611655104","volume":"104","author":"X Chen","year":"2007","unstructured":"Chen X, Trivedi PP, Ge B, Krzewski K, Strominger JL. Many NK cell receptors activate ERK2 and JNK1 to trigger microtubule organizing center and granule polarization and cytotoxicity. Proc Natl Acad Sci USA. 2007;104:6329\u201334. https:\/\/doi.org\/10.1073\/pnas.0611655104.","journal-title":"Proc Natl Acad Sci USA"},{"key":"894_CR41","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI13505","volume":"108","author":"G Zhou","year":"2001","unstructured":"Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001;108:1167\u201374. https:\/\/doi.org\/10.1172\/JCI13505.","journal-title":"J Clin Invest"},{"key":"894_CR42","doi-asserted-by":"publisher","first-page":"E1075","DOI":"10.1152\/ajpendo.00110.2018","volume":"315","author":"F Kopietz","year":"2018","unstructured":"Kopietz F, Berggreen C, Larsson S, S\u00e4ll J, Ekelund M, Sakamoto K, et al. AMPK activation by A-769662 and 991 does not affect catecholamine-induced lipolysis in human adipocytes. Am J Physiol Endocrinol Metab. 2018;315:E1075\u2013E1085. https:\/\/doi.org\/10.1152\/ajpendo.00110.2018.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"894_CR43","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nri.2016.54","volume":"16","author":"M De la Roche","year":"2016","unstructured":"De la Roche M, Asano Y, Griffiths GM. Origins of the cytolytic synapse. Nat Rev Immunol. 2016;16:421\u201332. https:\/\/doi.org\/10.1038\/nri.2016.54.","journal-title":"Nat Rev Immunol"},{"key":"894_CR44","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nri2381","volume":"8","author":"JS Orange","year":"2008","unstructured":"Orange JS. Formation and function of the lytic NK-cell immunological synapse. Nat Rev Immunol. 2008;8:713\u201325. https:\/\/doi.org\/10.1038\/nri2381.","journal-title":"Nat Rev Immunol"},{"key":"894_CR45","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/nri1983","volume":"6","author":"I Voskoboinik","year":"2006","unstructured":"Voskoboinik I, Smyth MJ, Trapani JA. Perforin-mediated target-cell death and immune homeostasis. Nat Rev Immunol. 2006;6:940\u201352. https:\/\/doi.org\/10.1038\/nri1983.","journal-title":"Nat Rev Immunol"},{"key":"894_CR46","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nri3839","volume":"15","author":"I Voskoboinik","year":"2015","unstructured":"Voskoboinik I, Whisstock JC, Trapani JA. Perforin and granzymes: function, dysfunction and human pathology. Nat Rev Immunol. 2015;15:388\u2013400. https:\/\/doi.org\/10.1038\/nri3839.","journal-title":"Nat Rev Immunol"},{"key":"894_CR47","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-cellbio-100616-060615","volume":"33","author":"J Wu","year":"2017","unstructured":"Wu J, Akhmanova A. Microtubule-organizing centers. Annu Rev Cell Dev Biol. 2017;33:51\u201375. https:\/\/doi.org\/10.1146\/annurev-cellbio-100616-060615.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"894_CR48","doi-asserted-by":"crossref","unstructured":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:854\u201365.","DOI":"10.1016\/S0140-6736(98)07037-8"},{"key":"894_CR49","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3389\/fonc.2018.00284","volume":"8","author":"B Wegiel","year":"2018","unstructured":"Wegiel B, Vuerich M, Daneshmandi S, Seth P. Metabolic switch in the tumor microenvironment determines immune responses to anti-cancer therapy. Front Oncol. 2018;8:284. https:\/\/doi.org\/10.3389\/fonc.2018.00284.","journal-title":"Front Oncol"},{"key":"894_CR50","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O. On the origin of cancer cells. Science. 1956;123:309\u201314. https:\/\/doi.org\/10.1126\/science.123.3191.309.","journal-title":"Science"},{"key":"894_CR51","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/ncb2060","volume":"12","author":"A Nakano","year":"2010","unstructured":"Nakano A, Kato H, Watanabe T, Min KD, Yamazaki S, Asano Y, et al. AMPK controls the speed of microtubule polymerization and directional cell migration through CLIP-170 phosphorylation. Nat Cell Biol. 2010;12:583\u201390. https:\/\/doi.org\/10.1038\/ncb2060.","journal-title":"Nat Cell Biol"},{"key":"894_CR52","doi-asserted-by":"publisher","first-page":"eaaz1965","DOI":"10.1126\/scisignal.aaz1965","volume":"13","author":"V Zurli","year":"2020","unstructured":"Zurli V, Montecchi T, Heilig R, Poschke I, Volkmar M, Wimmer G, et al. Phosphoproteomics of CD2 signaling reveals AMPK-dependent regulation of lytic granule polarization in cytotoxic T cells. Sci Signal. 2020;13:eaaz1965. https:\/\/doi.org\/10.1126\/scisignal.aaz1965.","journal-title":"Sci Signal"},{"key":"894_CR53","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/S0140-6736(18)31541-1","volume":"392","author":"SC Palmer","year":"2018","unstructured":"Palmer SC, Strippoli GFM. Metformin as first-line treatment for type 2 diabetes. Lancet. 2018;392:120. https:\/\/doi.org\/10.1016\/S0140-6736(18)31541-1.","journal-title":"Lancet."},{"key":"894_CR54","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.cmet.2015.01.003","volume":"21","author":"L He","year":"2015","unstructured":"He L, Wondisford FE. Metformin action: concentrations matter. Cell Metab. 2015;21:159\u201362. https:\/\/doi.org\/10.1016\/j.cmet.2015.01.003.","journal-title":"Cell Metab"},{"key":"894_CR55","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.2174\/138955708786369546","volume":"8","author":"S Correia","year":"2008","unstructured":"Correia S, Carvalho C, Santos MS, Seica R, Oliveira CR, Moreira PI. Mechanisms of action of metformin in type 2 diabetes and associated complications: an overview. Mini Rev Med Chem. 2008;8:1343\u201354. https:\/\/doi.org\/10.2174\/138955708786369546.","journal-title":"Mini Rev Med Chem"},{"key":"894_CR56","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.tips.2018.07.006","volume":"39","author":"A Vancura","year":"2018","unstructured":"Vancura A, Bu P, Bhagwat M, Zeng J, Vancurova I. Metformin as an anticancer agent. Trends Pharm Sci. 2018;39:867\u201378. https:\/\/doi.org\/10.1016\/j.tips.2018.07.006.","journal-title":"Trends Pharm Sci"},{"key":"894_CR57","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","volume":"330","author":"JM Evans","year":"2005","unstructured":"Evans JM, Donnelly LA, Emslie-Smith AM, Alessi DR, Morris AD. Metformin and reduced risk of cancer in diabetic patients. BMJ. 2005;330:1304\u20135. https:\/\/doi.org\/10.1136\/bmj.38415.708634.F7.","journal-title":"BMJ"},{"key":"894_CR58","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.tips.2012.11.005","volume":"34","author":"A Emami Riedmaier","year":"2013","unstructured":"Emami Riedmaier A, Fisel P, Nies AT, Schaeffeler E, Schwab M. Metformin and cancer: from the old medicine cabinet to pharmacological pitfalls and prospects. Trends Pharm Sci. 2013;34:126\u201335. https:\/\/doi.org\/10.1016\/j.tips.2012.11.005.","journal-title":"Trends Pharm Sci"},{"key":"894_CR59","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.tips.2016.03.004","volume":"37","author":"S Prasad","year":"2016","unstructured":"Prasad S, Gupta SC, Aggarwal BB. Serendipity in cancer drug discovery: rational or coincidence? Trends Pharm Sci. 2016;37:435\u201350. https:\/\/doi.org\/10.1016\/j.tips.2016.03.004.","journal-title":"Trends Pharm Sci"},{"key":"894_CR60","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3389\/fonc.2017.00243","volume":"7","author":"V Zingales","year":"2017","unstructured":"Zingales V, Distefano A, Raffaele M, Zanghi A, Barbagallo I, Vanella L. Metformin: a bridge between diabetes and prostate cancer. Front Oncol. 2017;7:243. https:\/\/doi.org\/10.3389\/fonc.2017.00243.","journal-title":"Front Oncol"},{"key":"894_CR61","doi-asserted-by":"publisher","first-page":"55622","DOI":"10.18632\/oncotarget.16973","volume":"8","author":"XL Zhou","year":"2017","unstructured":"Zhou XL, Xue WH, Ding XF, Li LF, Dou MM, Zhang WJ, et al. Association between metformin and the risk of gastric cancer in patients with type 2 diabetes mellitus: a meta-analysis of cohort studies. Oncotarget. 2017;8:55622\u201331. https:\/\/doi.org\/10.18632\/oncotarget.16973.","journal-title":"Oncotarget"},{"key":"894_CR62","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.molimm.2015.07.034","volume":"68","author":"RP Donnelly","year":"2015","unstructured":"Donnelly RP, Finlay DK. Glucose, glycolysis and lymphocyte responses. Mol Immunol. 2015;68:513\u20139. https:\/\/doi.org\/10.1016\/j.molimm.2015.07.034.","journal-title":"Mol Immunol"},{"key":"894_CR63","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1146\/annurev-immunol-032713-120236","volume":"32","author":"K Ganeshan","year":"2014","unstructured":"Ganeshan K, Chawla A. Metabolic regulation of immune responses. Annu Rev Immunol. 2014;32:609\u201334. https:\/\/doi.org\/10.1146\/annurev-immunol-032713-120236.","journal-title":"Annu Rev Immunol"},{"key":"894_CR64","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/mco2.6","volume":"1","author":"R Shi","year":"2020","unstructured":"Shi R, Tang YQ, Miao H. Metabolism in tumor microenvironment: Implications for cancer immunotherapy. MedComm. 2020;1:47\u201368. https:\/\/doi.org\/10.1002\/mco2.6. 2020","journal-title":"MedComm"},{"key":"894_CR65","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1042\/BST20150116","volume":"43","author":"DK Finlay","year":"2015","unstructured":"Finlay DK. Metabolic regulation of natural killer cells. Biochem Soc Trans. 2015;43:758\u201362. https:\/\/doi.org\/10.1042\/BST20150116.","journal-title":"Biochem Soc Trans"},{"key":"894_CR66","doi-asserted-by":"publisher","unstructured":"Lopes N, McIntyre C, Martin S, Raverdeau M, Raverdeau N, Kohlgruber AC, et al. Distinct metabolic programs established in the thymus control effector functions of gammadelta T cell subsets in tumor microenvironments. Nat Immunol. 2021. https:\/\/doi.org\/10.1038\/s41590-020-00848-3.","DOI":"10.1038\/s41590-020-00848-3"},{"key":"894_CR67","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","volume":"24","author":"A Brand","year":"2016","unstructured":"Brand A, Singer K, Koehl GE, Kolitzus M, Schoenhammer G, Thiel A, et al. LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab. 2016;24:657\u201371. https:\/\/doi.org\/10.1016\/j.cmet.2016.08.011.","journal-title":"Cell Metab"},{"key":"894_CR68","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","volume":"109","author":"K Fischer","year":"2007","unstructured":"Fischer K, Hoffmann P, Voelkl S, Meidenbauer N, Ammer J, Edinger M, et al. Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood. 2007;109:3812\u20139. https:\/\/doi.org\/10.1182\/blood-2006-07-035972.","journal-title":"Blood"},{"key":"894_CR69","doi-asserted-by":"publisher","first-page":"e1002202","DOI":"10.1371\/journal.pbio.1002202","volume":"13","author":"R Haas","year":"2015","unstructured":"Haas R, Smith J, Rocher-Ros V, Nadkarni S, Montero-Melendez T, D\u2019Acquisto F, et al. Lactate regulates metabolic and pro-inflammatory circuits in control of T cell migration and effector functions. PLoS Biol. 2015;13:e1002202. https:\/\/doi.org\/10.1371\/journal.pbio.1002202.","journal-title":"PLoS Biol"},{"key":"894_CR70","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3389\/fimmu.2018.00307","volume":"9","author":"A Kabanova","year":"2018","unstructured":"Kabanova A, Zurli V, Baldari CT. Signals controlling lytic granule polarization at the cytotoxic immune synapse. Front Immunol. 2018;9:307. https:\/\/doi.org\/10.3389\/fimmu.2018.00307.","journal-title":"Front Immunol"},{"key":"894_CR71","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/369031a0","volume":"369","author":"D Kagi","year":"1994","unstructured":"Kagi D, Ledermann B, B\u00fcrki K, Seiler P, Odermatt B, Olsen KJ, et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 1994;369:31\u201337. https:\/\/doi.org\/10.1038\/369031a0.","journal-title":"Nature"},{"key":"894_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2016.81","volume":"48","author":"SM Jeon","year":"2016","unstructured":"Jeon SM. Regulation and function of AMPK in physiology and diseases. Exp Mol Med. 2016;48:e245. https:\/\/doi.org\/10.1038\/emm.2016.81.","journal-title":"Exp Mol Med"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-022-00894-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-022-00894-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-022-00894-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T10:26:00Z","timestamp":1669285560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-022-00894-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,11]]},"references-count":72,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["894"],"URL":"https:\/\/doi.org\/10.1038\/s41423-022-00894-x","relation":{},"ISSN":["2042-0226"],"issn-type":[{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,11]]},"assertion":[{"value":"20 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}